We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00886860
First Posted: April 23, 2009
Last Update Posted: July 14, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Mahidol University
April 22, 2009
April 23, 2009
July 14, 2010
May 2009
December 2009   (Final data collection date for primary outcome measure)
success rate of cervical ripening in labor induction [ Time Frame: 12 hours after intervention ]
Same as current
Complete list of historical versions of study NCT00886860 on ClinicalTrials.gov Archive Site
number of vaginal delivery [ Time Frame: 24 hours ]
Same as current
Not Provided
Not Provided
 
The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol
The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol
The purpose of this study is to compare the efficacy for cervical ripening in labor induction between titrated and conventional oral misoprostol
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
  • Cervical Ripening
  • Labor Induction
  • Drug: misoprostol
    misoprostol 50 micrograms oral every 4 hours until cervical dilatation 3 cm
    Other Name: cytotec
  • Drug: misoprostol
    misoprostol 20 micrograms oral every hours until cervical dilatation 3 cm
    Other Name: cytotec
  • Active Comparator: conventional oral misoprostol
    misoprostol 50 micrograms oral every 4 hours until cervical dilatation 3 centimeters
    Intervention: Drug: misoprostol
  • Experimental: titrated oral misoprostol
    misoprostol 20 micrograms oral every hour until cervical dilatation 3 centimeters
    Intervention: Drug: misoprostol
Thaisomboon A, Russameecharoen K, Wanitpongpan P, Phattanachindakun B, Changnoi A. Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. Int J Gynaecol Obstet. 2012 Jan;116(1):13-6. doi: 10.1016/j.ijgo.2011.07.027. Epub 2011 Sep 28.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
64
March 2010
December 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • age 18 years old or more
  • singleton pregnancy at 37 weeks gestation or more
  • cephalic presentation
  • reassuring fetal heart rate pattern
  • admission for labor induction due to medical or obstetrical conditions
  • bishop score less than 6
  • giving consent and having signed the consent form for this study

Exclusion Criteria:

  • parity more than 3
  • estimated fetal weight more than 3,500 grams
  • non-reassuring fetal heart rate pattern
  • having contraindication for vaginal delivery
  • previous uterine scar
  • suspected abruptio placenta with non-reassuring fetal heart rate pattern
  • abnormal bleeding per vagina, except bloody show
  • PROM
  • having underlying cardiac, hepatic, or renal diseases
  • having history of allergy to misoprostol or prostaglandin analogues
  • cervical dilatation 3 centimeters or more
  • uterine contraction 3 times or more in 10 minute
Sexes Eligible for Study: Female
18 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Thailand
 
 
NCT00886860
091/2552(EC2)
Yes
Not Provided
Not Provided
Kusol Russameecharoen, MD., Faculty of Medicine Siriraj Hospital, Mahidol University
Mahidol University
Not Provided
Study Director: Kusol Russameecharoen, MD Siriraj Hospital, Mahidol University Bangkok, Bangkok, Thailand
Mahidol University
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP